Generic drug growth story: Sass

Now watching

Next video starts in : 7 Play

Generic drug growth story: Sass

Generic drug growth story: Sass
Replay video
Up next

'Marked improvement' in U.S. banking system: Yellen

Unlock your personal NFL Now stream by signing in to NFL.com

Generic drug growth story: Sass

by CNBC Videos 2:35 mins

Martin Sass, CEO & Chairman, MD Sass, thinks there's a 95 percent chance the politicians will work out their differences. He continues to believe generic drug makers are great investment opportunities.

View Comments (0)